| Term 
 
        | Enalapril and other "april"s |  | Definition 
 
        | CH 13 Drugs Used in Heart Failure Angiotensin Antagonists   
| Angiotension-converting enzyme (ACE) inhibitors - reduces AII formation by inhibiting conversion of AI to AII; arteriolar and venous dilation, ↓aldosterone secretion, ↓ cardiac remodeling, ↑ CO | Cough, hyperkalemia, Angioneurotic edema Fetal abnormalities Altered taste Dry cough | Chronic heart failure, hypertension, diabetic renal disease |    |  | 
        |  | 
        
        | Term 
 
        | Losartan and other "artan"s |  | Definition 
 
        | CH 13 Drugs Used in Heart Failure Angiotensin Antagonists   
| Angiotension (AT1) receptor blockers (ARBs); similar effect as ACE inhibitors | Hyperkalemia, angioneurotic edema Fetal abnormalities | Used in patients intolerant to ACE inhibitors  |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 13 Drugs Used in Heart Failure Cardiac Glycoside   
| Na+,K+ ATPase inhibition results in reduced Ca+2 expulsion and ↑ Ca+2 stored in sarcoplasmic reticulum leading to ↑ contractility; parasympathomimetic effects (e.g. sensitation of baroreceptors, central vagal stimulation, facilitation of muscarinic transmission) | Nausea, vomiting, diarrhea, cardiac arrhythmias altered color vision  Chronic toxicity:  a calcium overload, which can lead to arrhythmia and tachycardia. Acute toxicity: hyperkalemia and cardiac arrest. | Heart failure, rapid ventricular rate in atrial fibrillation |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 13 Drugs Used in Heart Failure Beta-Adrenoceptor Agonist   
| β1-selective agonist, increases cAMP synthesis; increases cardiac contractility, output, with a decrease in ventricular filling pressure | Arrhythmias and angina in patients with coronary artery disease; tachyphylaxis | Acute decompensated heart failure, intermittent therapy in chronic failure reduces symptoms |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 13 Drugs Used in Heart Failure Bipyridines   
| Phosphodiesterase type 3 inhibition decreases cAMP breakdown and causes vasodilation and ↑ contractility | Nausea, vomiting, arrhythmias, thrombocytopenia, liver enzyme changes | Acute decompensated heart failure |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 13 Drugs Used in Heart Failure Endothelin Receptor Antagonist   
| Under normal conditions, endothelin causes pulmonary vasoconstriction. By blocking this interaction, bosentan ↓ pulmonary vascular resistance. | Hepatotoxicity, anemia, teratogenic, interacts with hormone-based contraception in women | Pulmonary artery hypertension |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 13 Drugs Used in Heart Failure Natriuretic Peptide   
| Synthetic form of brain natriuretic peptide (BNP) that activates BNP receptors; increases cGMP in smooth muscle cells causing vasodilation; also causes diuresis  | Excessive hypotension, renal damage | Acute (not chronic) heart failure given IV |    |  | 
        |  |